Skip to Content

Publications Search - Abstract View

Title: Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.
Authors: Haiman CA,  Chen GK,  Blot WJ,  Strom SS,  Berndt SI,  Kittles RA,  Rybicki BA,  Isaacs WB,  Ingles SA,  Stanford JL,  Diver WR,  Witte JS,  Hsing AW,  Nemesure B,  Rebbeck TR,  Cooney KA,  Xu J,  Kibel AS,  Hu JJ,  John EM,  Gueye SM,  Watya S,  Signorello LB,  Hayes RB,  Wang Z,  Yeboah E,  Tettey Y,  Cai Q,  Kolb S,  Ostrander EA,  Zeigler-Johnson C,  Yamamura Y,  Neslund-Dudas C,  Haslag-Minoff J,  Wu W,  Thomas V,  Allen GO,  Murphy A,  Chang BL,  Zheng SL,  Leske MC,  Wu SY,  Ray AM,  Hennis AJ,  Thun MJ,  Carpten J,  Casey G,  Carter EN,  Duarte ER,  Xia LY,  Sheng X,  Wan P,  Pooler LC,  Cheng I,  Monroe KR,  Schumacher F,  Le Marchand L,  Kolonel LN,  Chanock SJ,  Van Den Berg D,  Stram DO,  Henderson BE
Journal: Nat Genet
Date: 2011 Jun
Branches: CGR, IIB, LTG, OEEB
PubMed ID: 21602798
PMC ID: PMC3102788
Abstract: In search of common risk alleles for prostate cancer that could contribute to high rates of the disease in men of African ancestry, we conducted a genome-wide association study, with 1,047,986 SNP markers examined in 3,425 African-Americans with prostate cancer (cases) and 3,290 African-American male controls. We followed up the most significant 17 new associations from stage 1 in 1,844 cases and 3,269 controls of African ancestry. We identified a new risk variant on chromosome 17q21 (rs7210100, odds ratio per allele = 1.51, P = 3.4 × 10(-13)). The frequency of the risk allele is ∼5% in men of African descent, whereas it is rare in other populations (<1%). Further studies are needed to investigate the biological contribution of this allele to prostate cancer risk. These findings emphasize the importance of conducting genome-wide association studies in diverse populations.